Products
Prognostic & predictive Test for Liver cancer
A prognostic and predictive combined test to predict the 5-year survival as well as the efficacy of treatment for liver cancer patients. The test can
- Significantly reduce the expense of diagnostic test by one-stop service
- Support the determination of treatment (surgery / Nexevar®)
The service is expected to be launched in the second half of 2020.
New Health Technology
The Ministry of Health and Welfare
Notice 2010-83
Success in validation (Japan)
Journal of Surgical Research January 2020(245)302-308
OncoHePaTest® KIT Approved
Notice 13-511
Nexavar® CDx paper publication
Liver Cancer (E-published 2020)
Nexavar® CDx KIT Approved
Notice 13-745
